Emany Sravan Kumar Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$400,334.96
Insider Sells Quantity
2
Insider Sells Sum
$120,925.76

Insider Activity of Emany Sravan Kumar

According to the SEC Form 4 filings, Emany Sravan Kumar, being in a position of

  1. Chief Financial Officer at Beam Therapeutics Inc.,
    оver the last 12 months, has bought 0 shares, and sold 6294 shares for $170,567,
    over all time since 2025-12-31, has bought 0 shares, and sold 6294 shares for $170,567.

Biography of Emany Sravan Kumar

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $170,5671100

Comparison of Insiders on Amount of Buys and Sells

2025-12-31SaleBeam Therapeutics Inc.
BEAM
Chief Financial Officer
6,294
0.006%
$27.10$170,567-0.36%
2024-11-18SaleIronwood Pharmaceuticals, Inc.
IRWD
SVP, COO and CFO
11,001
0.007%
$4.08$44,884-64.55%
2024-03-04PurchaseIronwood Pharmaceuticals, Inc.
IRWD
SVP, Chief Financial Officer
10,684
0.0069%
$9.38$100,216-50.32%
2023-09-15PurchaseIronwood Pharmaceuticals, Inc.
IRWD
SVP, Chief Financial Officer
36,072
0.0231%
$8.32$300,119+4.32%
2022-11-21SaleIronwood Pharmaceuticals, Inc.
IRWD
SVP, Chief Financial Officer
6,578
0.0043%
$11.56$76,042-7.07%
Total: 5
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.